Thomas M. Krummel - Jun 21, 2022 Form 4 Insider Report for PROCEPT BioRobotics Corp (PRCT)

Role
Director
Signature
/s/ Alaleh Nouri, Attorney-in-Fact for Thomas M. Krummel
Stock symbol
PRCT
Transactions as of
Jun 21, 2022
Transactions value $
-$662,746
Form type
4
Date filed
6/22/2022, 07:11 PM
Previous filing
Jun 9, 2022
Next filing
Nov 30, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction PRCT Common Stock Options Exercise $13.9K +10.5K +12.64% $1.33* 93.4K Jun 21, 2022 Direct F1
transaction PRCT Common Stock Options Exercise $30.8K +6.83K +7.32% $4.51* 100K Jun 21, 2022 Direct F1
transaction PRCT Common Stock Options Exercise $12.1K +2.69K +2.68% $4.51* 103K Jun 22, 2022 Direct F1
transaction PRCT Common Stock Sale -$379K -10.5K -10.18% $36.14 92.4K Jun 21, 2022 Direct F1, F2
transaction PRCT Common Stock Sale -$247K -6.83K -7.39% $36.14 85.6K Jun 21, 2022 Direct F1, F3
transaction PRCT Common Stock Sale -$94.1K -2.69K -3.14% $35.00 82.9K Jun 21, 2022 Direct F1, F4

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction PRCT Stock Option (Right to Buy) Options Exercise $0 -10.5K -100% $0.00* 0 Jun 21, 2022 Common Stock 10.5K $1.33 Direct F1, F5
transaction PRCT Stock Option (Right to Buy) Options Exercise $0 -6.83K -25.97% $0.00 19.5K Jun 21, 2022 Common Stock 6.83K $4.51 Direct F1, F5
transaction PRCT Stock Option (Right to Buy) Options Exercise $0 -2.69K -13.8% $0.00 16.8K Jun 22, 2022 Common Stock 2.69K $4.51 Direct F1, F5
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The option exercise and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 18, 2022.
F2 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $35.00 to $38.15. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (2) through (4) to this Form 4.
F3 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $35.00 to $38.15.
F4 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $35.00 to $35.01.
F5 The option is fully vested and exercisable.